Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.
2.

Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta.

Sasaki K, Yagi H, Bronson RT, Tominaga K, Matsunashi T, Deguchi K, Tani Y, Kishimoto T, Komori T.

Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12359-63.

3.

AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis.

Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR.

Cell. 1996 Jan 26;84(2):321-30.

5.

The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo.

Wang Q, Stacy T, Miller JD, Lewis AF, Gu TL, Huang X, Bushweller JH, Bories JC, Alt FW, Ryan G, Liu PP, Wynshaw-Boris A, Binder M, Marín-Padilla M, Sharpe AH, Speck NA.

Cell. 1996 Nov 15;87(4):697-708.

6.

AML1(-/-) embryos do not express certain hematopoiesis-related gene transcripts including those of the PU.1 gene.

Okada H, Watanabe T, Niki M, Takano H, Chiba N, Yanai N, Tani K, Hibino H, Asano S, Mucenski ML, Ito Y, Noda T, Satake M.

Oncogene. 1998 Nov 5;17(18):2287-93.

7.

PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials.

Bae SC, Ogawa E, Maruyama M, Oka H, Satake M, Shigesada K, Jenkins NA, Gilbert DJ, Copeland NG, Ito Y.

Mol Cell Biol. 1994 May;14(5):3242-52.

8.
9.

Expression of the Runt domain-encoding PEBP2 alpha genes in T cells during thymic development.

Satake M, Nomura S, Yamaguchi-Iwai Y, Takahama Y, Hashimoto Y, Niki M, Kitamura Y, Ito Y.

Mol Cell Biol. 1995 Mar;15(3):1662-70.

10.

Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene.

Yergeau DA, Hetherington CJ, Wang Q, Zhang P, Sharpe AH, Binder M, Marín-Padilla M, Tenen DG, Speck NA, Zhang DE.

Nat Genet. 1997 Mar;15(3):303-6.

PMID:
9054947
11.

Zebrafish homolog of the leukemia gene CBFB: its expression during embryogenesis and its relationship to scl and gata-1 in hematopoiesis.

Blake T, Adya N, Kim CH, Oates AC, Zon L, Chitnis A, Weinstein BM, Liu PP.

Blood. 2000 Dec 15;96(13):4178-84.

12.

VWRPY motif-dependent and -independent roles of AML1/Runx1 transcription factor in murine hematopoietic development.

Nishimura M, Fukushima-Nakase Y, Fujita Y, Nakao M, Toda S, Kitamura N, Abe T, Okuda T.

Blood. 2004 Jan 15;103(2):562-70. Epub 2003 Sep 22.

13.

Regulation mechanisms for the heterodimeric transcription factor, PEBP2/CBF.

Bae SC, Ito Y.

Histol Histopathol. 1999 Oct;14(4):1213-21. Review.

PMID:
10506937
14.

The core-binding factor beta subunit is required for bone formation and hematopoietic maturation.

Miller J, Horner A, Stacy T, Lowrey C, Lian JB, Stein G, Nuckolls GH, Speck NA.

Nat Genet. 2002 Dec;32(4):645-9. Epub 2002 Nov 18.

PMID:
12434155
16.
17.

Cloning, mapping and expression of PEBP2 alpha C, a third gene encoding the mammalian Runt domain.

Bae SC, Takahashi E, Zhang YW, Ogawa E, Shigesada K, Namba Y, Satake M, Ito Y.

Gene. 1995 Jul 4;159(2):245-8.

PMID:
7622058
18.

The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.

Lo Coco F, Pisegna S, Diverio D.

Haematologica. 1997 May-Jun;82(3):364-70. Review.

20.

Core-binding factor: a central player in hematopoiesis and leukemia.

Speck NA, Stacy T, Wang Q, North T, Gu TL, Miller J, Binder M, Marín-Padilla M.

Cancer Res. 1999 Apr 1;59(7 Suppl):1789s-1793s. Review.

PMID:
10197598
Items per page

Supplemental Content

Write to the Help Desk